$2.93 -0.13 (%) Synta Pharmaceuticals Corp - NASDAQ

Oct. 22, 2014 | 04:00 PM

Partner Headlines

  1. InterMune's Roche Deal Sends Peer Group Up

    Benzinga | Aug. 25, 2014 | 11:38AM EST
  2. Synta Announces Advancement Of Ganetespib Into Phase 3 Extension Of AML LI-1 Study For Patients With AML And High-Risk MDS

    Benzinga | Jul. 21, 2014 | 16:30PM EST
  3. Events Scheduled for Week of Jun 23rd to Jun 27th, 2014

    Benzinga | Jun. 23, 2014 | 18:25PM EST
  4. 5-Star Biotech Stock Watch: Synta Pharmaceuticals

    Benzinga | Jun. 18, 2014 | 15:26PM EST
  5. 3 Biotech Stocks Backed By Big Money

    Benzinga | Jun. 16, 2014 | 14:27PM EST
  6. Morning Market Movers

    Benzinga | Mar. 20, 2014 | 09:39AM EST
  7. Benzinga's Top #PreMarket Gainers

    Benzinga | Mar. 20, 2014 | 08:08AM EST
  8. Top Trending Tickers On StockTwits For March 12

    Benzinga | Mar. 12, 2014 | 10:25AM EST
  9. Morning Movers for March 12th, 2014

    Benzinga | Mar. 12, 2014 | 10:15AM EST
  10. Morning Market Losers

    Benzinga | Mar. 12, 2014 | 09:49AM EST
  11. Benzinga's Top #PreMarket Losers

    Benzinga | Mar. 12, 2014 | 08:47AM EST
  12. UPDATE: Stifel Downgrades Synta Pharmaceuticals as GALAXY-2 Adjustments Further Diminish Likelihood For Success

    Benzinga | Mar. 12, 2014 | 08:13AM EST
  13. Earnings Scheduled For March 11, 2014

    Benzinga | Mar. 11, 2014 | 05:33AM EST
  14. Stocks Hitting 52-Week Lows

    Benzinga | Nov. 13, 2013 | 09:57AM EST
  15. Synta Pharmaceuticals Announces Proposed Public Offering of Common Stock

    Benzinga | Nov. 12, 2013 | 16:09PM EST
  16. Synta Presents Positive One-Year Follow-up Results for GALAXY-1 Trial of Ganetespib in NSCLC

    Benzinga | Oct. 26, 2013 | 10:12AM EST
  17. Synta Announces Encouraging Results of Ganetespib GALAXY-1 Trial at ECC 2013

    Benzinga | Sep. 28, 2013 | 09:26AM EST
  18. Shares of Synta Moving Higher Following News of Fast Track Designation for Ganetespib

    Benzinga | Sep. 12, 2013 | 08:27AM EST
  19. These Three Speculative Companies Are Loved By Insiders and Institutions

    Benzinga | Aug. 22, 2013 | 11:55AM EST
  20. Synta Provides Clinical Updates

    Benzinga | Aug. 1, 2013 | 06:51AM EST
  21. Synta Provides Clinical Updates

    Benzinga | Aug. 1, 2013 | 06:51AM EST
  22. Market Wrap for Monday, July 29: Stocks Record Moderate Losses to Start Trading Week

    Benzinga | Jul. 29, 2013 | 16:23PM EST
  23. Synta Pharmaceuticals Surges 45% on Positive ENCHANT-1 Breast Cancer Results

    Benzinga | Jul. 29, 2013 | 10:18AM EST
  24. Synta Announces ENCHANT-1 Breast Cancer Results Support Transition to Second Stage of Trial

    Benzinga | Jul. 29, 2013 | 07:11AM EST
  25. Synta Pharmaceuticals Inc. (SNTA) CEO Safi R Bahcall buys 10,000 Shares

    GuruFocus | Nov. 13, 2012 | 10:52AM EST
  26. Synta Pharmaceuticals, Inc. (SNTA) CEO Safi R Bahcall buys 10,000 Shares

    GuruFocus | Nov. 13, 2012 | 03:35AM EST
  27. Synta Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 6, 2012 | 04:35AM EST
  28. UPDATE: Jefferies Raises PT to $22 on Synta Pharmaceuticals on GALAXY Update

    Benzinga | Oct. 1, 2012 | 06:20AM EST
  29. UPDATE: Stifel Nicolaus Initiates Synta Pharmaceuticals at Hold; Enthusiasm Outpaces Expectations

    Benzinga | Aug. 30, 2012 | 07:02AM EST
  30. Synta Announces $25.8 Million Registered Direct Offering of Common Stock

    Benzinga | Jul. 26, 2012 | 01:34AM EST
  31. Weekly CEO Buys Highlight: SNTA, MEI, PZG, MCHX, CMXI

    GuruFocus | Jul. 7, 2012 | 17:43PM EST
  32. Synta Pharmaceuticals Inc. (SNTA) CEO Safi R Bahcall buys 10,000 Shares

    GuruFocus | Jul. 2, 2012 | 05:11AM EST
  33. Health Care Sector Wrap

    FoxBusiness | Jun. 28, 2012 | 10:47AM EST
  34. Synta Pharmaceuticals (SNTA) Up 15% after Jefferies Issues Bullish Note

    MarketIntelligenceCenter | Jun. 25, 2012 | 13:10PM EST
  35. UPDATE: Jefferies Raises PT on Synta from $7 to $14

    Benzinga | Jun. 25, 2012 | 08:33AM EST
  36. Teva Pharmaceutical Industries, Constellation Brands Among Stocks Up on High Volume Monday

    FoxBusiness | Jun. 25, 2012 | 06:33AM EST
  37. Quest Software, Pharmacyclics, Other Stocks Hit 52-Week Highs Monday

    FoxBusiness | Jun. 25, 2012 | 06:32AM EST
  38. Merck &, Onyx Pharmaceuticals Among Stocks Hitting 52-Week Highs Friday

    FoxBusiness | Jun. 22, 2012 | 06:33AM EST
  39. UPDATE: BMO Capital Markets Upgrades Synta Pharmaceuticals to Outperform on HSP90 Opportunity

    Benzinga | Jun. 4, 2012 | 08:45AM EST
  40. Benzinga's Top Pre-Market Losers

    Benzinga | Jun. 1, 2012 | 02:09AM EST
  41. Today's Top Small-Cap Winners!

    Benzinga | May. 31, 2012 | 10:18AM EST
  42. UPDATE: Jefferies Initiates Coverage on Synta Pharmaceuticals

    Benzinga | May. 22, 2012 | 03:20AM EST
  43. Synta Pharmaceuticals Inc. Reports Operating Results (10-K)

    GuruFocus | Feb. 22, 2012 | 00:57AM EST
  44. Earnings Scheduled For February 22

    Benzinga | Feb. 21, 2012 | 21:20PM EST
  45. These 4 Biotech Stocks Are a Buy Now

    GuruFocus | Feb. 8, 2012 | 11:16AM EST
  46. Notable Put Options Activity in Synta Pharmaceuticals

    Benzinga | Feb. 6, 2012 | 03:48AM EST
  47. UPDATE: Synta Prices 7M Shares at $4.40 Each

    Benzinga | Jan. 6, 2012 | 02:04AM EST
  48. McNicoll Lewis & Vlak Reiterates Buy, $10 Target on Synta Pharmaceuticals

    Benzinga | Dec. 9, 2011 | 02:41AM EST
Trading Center